SB418
Therapeutic interchange; authorizes pharmacists to preform, adaptation of prescriptions.
Status:
In Senate
Latest Action:
Feb. 5, 2026
Senate: Reported from Education and Health (14-Y 0-N)
Chief Patron:
Barbara Favola (D)
Session:
2026 Regular Session
Summary
As Introduced. Therapeutic interchange and adaptation.
Authorizes pharmacists to perform therapeutic interchanges by substituting a drug with another drug in the same therapeutic class when such substitution lowers the cost or is cost-neutral to the patient or the prescribed drug is in a drug shortage and the substitution conforms to Board of Pharmacy regulations. The bill ... (More) directs the Board of Pharmacy to determine which therapeutic classes of drugs shall be eligible for therapeutic interchange and which classes shall be prohibited. The bill also authorizes pharmacists to adapt prescriptions by changing the dosage form or quantity of a medication or by completing missing information on a prescription when there is evidence to support such change. (Less)-
Bill History
- 01/13/2026 - Senate: Prefiled and ordered printed; Offered 01-14-2026 26104862D
- 01/13/2026 - Senate: Referred to Committee on Education and Health
- 01/29/2026 - Senate: Fiscal Impact Statement from Department of Planning and Budget (SB418)
- 01/30/2026 - Senate: Assigned Education sub: Health Professions
- 02/05/2026 - Senate: Reported from Education and Health (14-Y 0-N)
